Kancera AB (OSTO:KAN) Days Sales Outstanding : 0.00 (As of Sep. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Kancera AB Days Sales Outstanding?

Kancera AB's average Accounts Receivable for the three months ended in Sep. 2023 was kr2.75 Mil. Kancera AB's Revenue for the three months ended in Sep. 2023 was kr0.00 Mil.

The historical rank and industry rank for Kancera AB's Days Sales Outstanding or its related term are showing as below:

OSTO:KAN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 23.66 Med: 319.63 Max: 2006.42
Current: 2006.42

During the past 13 years, Kancera AB's highest Days Sales Outstanding was 2006.42. The lowest was 23.66. And the median was 319.63.

OSTO:KAN's Days Sales Outstanding is ranked worse than
97.87% of 892 companies
in the Biotechnology industry
Industry Median: 72.245 vs OSTO:KAN: 2006.42

Kancera AB's Days Sales Outstanding declined from Sep. 2022 (1,955.24) to Sep. 2023 (0.00).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

Kancera AB Days Sales Outstanding Historical Data

The historical data trend for Kancera AB's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kancera AB Days Sales Outstanding Chart

Kancera AB Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Days Sales Outstanding

Get a 7-Day Free Trial

319.63

34.16

Kancera AB Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Days Sales Outstanding	Get a 7-Day Free Trial															1,955.24	15,931.57	-	679.37	-

Competitive Comparison of Kancera AB's Days Sales Outstanding

For the Biotechnology subindustry, Kancera AB's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kancera AB's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kancera AB's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Kancera AB's Days Sales Outstanding falls into.

Kancera AB Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Kancera AB's Days Sales Outstanding for the fiscal year that ended in Dec. 2022 is calculated as

	Days Sales Outstanding (A: Dec. 2022 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2021 )	+	Accounts Receivable (A: Dec. 2022 ))	/	count )	/	Revenue (A: Dec. 2022 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0.753	*	365
=	0					/	0.753	*	365
=	0.00

Kancera AB's Days Sales Outstanding for the quarter that ended in Sep. 2023 is calculated as:

	Days Sales Outstanding (Q: Sep. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Sep. 2023 ))	/	count )	/	Revenue (A: Sep. 2023 )	*	Days in Period
=	( (3.395	+	2.099)	/	2 )	/	0	*	365 / 4
=	2.747					/	0	*	365 / 4
=	N/A

Kancera AB (OSTO:KAN) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Kancera AB Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Kancera AB's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Kancera AB (OSTO:KAN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kancera AB (OSTO:KAN) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

3EE0:Germany

Address

Karolinska Institutet Science Park, Banvaktsvagen 22, Solna, SWE, 171 48

Website

http://www.kancera.com

Kancera AB develops drugs that counteract damage in acute and chronic inflammation. The fractalkin blockers KAND567 and KAND145 are developed to effectively counteract hyperinflamation in various disease states and thereby protect vital organs in conjunction with myocardial infarction and severe viral infections. Kancera is planning two phase II clinical trials, in covid-19 and in cardiac patients. The company conducts research and development within the Karolinska Institute Science Park in Stockholm.

Kancera AB (OSTO:KAN) Headlines

No Headlines